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complications. Chantler and Lakatta (2012) elegantly describe the 
concept of arterial ventricular coupling and provide valuable infor-
mation on how aging, in the absence and presence of cardiovascular 
disease, affects the coupling both at rest and during exercise, and 
its pathophysiological consequences.
In addition, vascular aging has been largely associated with 
senescence of the vascular endothelium. El Assar et al. (2012) 
present a wide overview of the mechanisms that participate on 
endothelial dysfunction that accompanies vascular aging, analyzing 
the synergisms, and interactions between them, some of the cellular 
mechanisms related to endothelial senescence as well as the preven-
tion or reversion of those mechanisms that produce endothelial 
dysfunction. Cau et al. (2012) based on evidence from experimental 
models review the contribution of NO synthase (NOS) isoform 
alterations on aging-associated vascular dysfunctions, addressing 
the potential prevention by some drugs that modulate the expres-
sion/activity of NOS. Finally, Blanco and Bernabéu (2012) sum-
marize data supporting the link between the splicing factor SRSF1 
and endothelial cell senescence and suggest the existence of a com-
mon genetic program involving alternative splicing of a cluster of 
genes, which contributes to a senescent environment in the vessels. 
Nonetheless, aging-associated damage to the endothelium may not 
simply be a consequence of the endothelial cell malfunctioning, 
but also as a result of impaired maintenance repair systems by 
endothelial progenitor cell (EPC). As discussed by Williamson et al. 
(2012), a deterioration of endogenous EPC function with age may 
culminate in a decreased capacity for neovascularization and/or 
reduced re-endothelialization of vascular lesions, facilitating the 
development, progression, and clinical sequelae of cardiovascular 
disease.
Growing evidence show that the progress of vascular aging in 
women follows a different chronology than in men. The gender-
associated difference in the pathophysiology of cardiovascular dis-
ease has generated heated discussion, although a general consensus 
has validated a role of sex hormones in the modulation of vascular 
function and dysfunction. This research topic covers two fronts in 
this field: Novella et al. (2012) review clinical and experimental data 
to clarify how menopause and aging contribute jointly to vascular 
senescence and how estrogen modulates vascular response at dif-
ferent ages; Lopes et al. (2012) discuss the conflicting information 
on the role of testosterone to the regulation of vascular function 
in elder men and women.
Last but not least, as suggested by Gragasin et al. (2012) the 
elderly is more frequently represented in common medical 
procedures and surgeries. Thus, understanding the circulatory 
“Man is as old as his arteries.” This old aphorism has been widely 
confirmed by epidemiological and observational studies estab-
lishing that cardiovascular diseases can be age-related in terms of 
their onset and progression. Besides, with aging come a number of 
physiological and morphological changes that alters cardiovascular 
function and lead to subsequently increased risk of cardiovascular 
disease, even in health asymptomatic individuals. Even though dif-
ferent adaptive mechanisms to protect blood vessels against mild 
stress have been described, the aging process induces a progressive 
failure of protective mechanisms, leading to vascular changes. The 
outcomes of the aging-related modifications are the impairment 
of homeostasis of the irrigated organs and resultant target organ 
damage.
The increasing mean age of the population in industrialized 
countries has turned out to be an economic and public health 
problem, as the increase in life expectancy goes in parallel with high 
incidence of several pathological conditions, despite unprecedented 
advances in prevention, diagnostics, and treatment. Of all aging-
related illness, cardiovascular diseases remain the leading cause of 
morbidity and mortality in the elderly, and thus it is imperative to 
understand the mechanism underlying cardiovascular senescence.
This Research Topic presents a forum of comprehensive reviews 
on distinct aspects of the pathophysiology of vascular aging to 
provide insights into the causes and consequences of this complex 
process and attempts to propose new therapeutic strategies for the 
management of vascular senescence. Such as the idea proposed 
by Ming et al. (2012) and discussed by Cau and Tostes (2012), 
which suggests that targeting mTORC1-S6K1 signaling could be 
a promising therapeutic modality to retard the aging process and 
treat cardiovascular disease in the elderly.
Vascular aging could be simply described as a consequence of 
natural physical stress and fatigue that could account for the major 
physical changes seen in elderly: dilation (after fracture of load-
bearing material) and stiffening (by transfer of stress to the more 
rigid collagenous component of the arterial wall). Although aging-
associated changes on vascular functioning are considered a set up 
for cardiovascular disease, modifications on cardiac, and central 
function could slow down or accelerate this set point. Therefore, it is 
crucial to understand how aging and other pathophysiological states 
affect the interaction between the heart and arterial network. The 
article by Wojciechowska et al. (2012) provides information on the 
changes with age in central and peripheral systolic blood pressure, 
based on data collected from randomly recruited European and 
Chinese subjects supporting a vicious circle between age-related 
stiffness, increasing systolic blood pressure, and  cardiovascular 
www.frontiersin.org August 2012 | Volume 3 | Article 325 | 1
Cau, S. B., and Tostes, R. C. (2012). mTOR inhibition: a promise for a young heart. 
Front. Physiol. 3:31. doi: 10.3389/fphys.2012.00031
Chantler, P. D., and Lakatta, E. G. (2012). Arterial-ventricular coupling with aging and 
disease. Front. Physiol. 3:90. doi: 10.3389/fphys.2012.00090
El Assar, M., Angulo, J., Vallejo, S., Peiró, C., Sánchez-Ferrer, C. F., and Rodríguez-Mañas, 
L. (2012). Mechanisms involved in the aging-induced vascular dysfunction. Front. 
Physiol. 3:132. doi: 10.3389/fphys.2012.00132
Gragasin, F. S., Bourque, S. L., and Davidge, S. T. (2012). Vascular aging and hemo-
dynamic stability in the intraoperative period. Front. Physiol. 3:74. doi: 10.3389/
fphys.2012.00074
Lopes, R. A., Neves, K. B., Carneiro, F. S., and Tostes, R. C. (2012). Testosterone and 
vascular function in aging. Front. Physiol. 3:89. doi: 10.3389/fphys.2012.00089
Ming, X. F., Montani, J. P., and Yang, Z. (2012). Perspectives of targeting mTORC1-S6K1 
in cardiovascular aging. Front. Physiol. 3:5. doi: 10.3389/fphys.2012.00005
Novella, S., Dantas, A. P., Segarra, G., Medina, P., and Hermenegildo, C. (2012). Vascular 
aging in women: Is estrogen the fountain of youth? Front. Physiol. 3:165. doi: 10.3389/
fphys.2012.00165
Williamson, K., Stringer, S. E., and Alexander, M. Y. (2012). Endothelial progenitor cells 
enter the aging arena. Front. Physiol. 3:30. doi: 10.3389/fphys.2012.00030
Wojciechowska, W., Li, Y., Stolarz-Skrzypek, K., Kawecka-Jaszcz, K., Staessen, J. A., 
Wang, J. G., on behalf of the European Project on Genes in Hypertension and the 
JingNing Study Investigators. (2012). Cross-sectional and longitudinal assessment 
of arterial stiffening with age in European and Chinese populations. Front. Physiol. 
3:209. doi: 10.3389/fphys.2012.00209
Received: 03 July 2012; accepted: 24 July 2012; published online: 10 August 2012.
Citation: Dantas A, Jiménez-Altayó F and Vila E (2012) Vascular aging: facts and factors. 
Front. Physio. 3:325. doi: 10.3389/fphys.2012.00325
This article was submitted to Frontiers in Vascular Physiology, a specialty of Frontiers in 
Physiology.
Copyright © 2012 Dantas, Jiménez-Altayó and Vila. This is an open-access article distrib-
uted under the terms of the Creative Commons Attribution License, which permits use, 
distribution and reproduction in other forums, provided the original authors and source 
are credited and subject to any copyright notices concerning any third-party graphics etc.
changes that accompany the aging process is therefore becoming 
increasingly timely and relevant. These authors discuss aspects 
of vascular control in aging that are particularly relevant in the 
maintenance of intraoperative hemodynamic stability reviewing 
the effect of certain notable anesthetic agents with respect to the 
aging vasculature.
Given the growing clinical relevance of the subject, we are 
pleased that our Research Topic has brought together basic and 
clinical scientists to spotlight on one of the greatest enemies of 
elder population: i.e., the vascular senescence. We hope that this 
Research Topic also place a special call on the need of studies to 
establish treatments and procedures to reduce the detrimental 
effects of vascular aging. It has been a great pleasure to be involved 
in this Research Topic and we would like to thank all of the authors, 
reviewers, and Frontiers staff for helping to make this Research 
Topic possible.
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